Menlo Park, CA · Founded 2018 · Privately Held (backing)
Developer of engineered cytokine therapeutics designed to facilitate disease-optimized treatments. Synthekine is based in Menlo Park, CA and was founded in 2018. Its last reported valuation was $500 million in Dec 2022. It has raised $289 million.
Last reported valuation
$500.0M
Oct 2026
Priced at
—
Total raised
$288.6M
Last round
—
Cap table — not yet on record
Synthekine's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Synthekine with a free account
·The complete investor list: 13 names
·Watch Synthekine: the Monday email on marks, rounds and moves
